Scutebata B exhibits significant potential in pharmaceutical applications, particularly in anti-inflammatory and neuroprotective therapies. It has demonstrated the ability to modulate key signaling pathways involved in oxidative stress and neuronal damage, making it a candidate for research in neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease. Additionally, its natural origin and structural properties support its use in developing plant-based medicinal products. Preliminary studies also suggest antimicrobial activity, indicating possible utility in treating certain bacterial infections. Ongoing research focuses on optimizing delivery methods and evaluating long-term efficacy in vivo.